[{"Assets_0_Q3_USD":11310800000.0,"CIK":"1585364","CommonStockDividendsPerShareDeclared_1_Q3_USD":0.21,"CommonStockSharesConverted_0_Q3_shares":136100000.0,"Country":"United States","EarningsPerShareBasic_1_Q3_USD":0.68,"EarningsPerShareBasic_3_Q3_USD":1.21,"EarningsPerShareDiluted_1_Q3_USD":0.67,"EarningsPerShareDiluted_3_Q3_USD":1.21,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"4754722726.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":298300000.0,"NetIncomeLossConverted_1_Q3_USD":92200000.0,"NetIncomeLossConverted_3_Q3_USD":165100000.0,"OfficialName":"Perrigo Company plc Ordinary Shares","RevenuesConverted_1_Q3_USD":1191100000.0,"RevenuesConverted_3_Q3_USD":3514600000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":5759100000.0,"StockholdersEquity_0_Q3_USD":5758800000.0,"Ticker":"PRGO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":136800000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":136400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":136000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":136000000.0,"filed":"20191106","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2019.0","name":"PERRIGO CO PLC","period":"20190930","qtrs":"0","uom":"USD"}]